Evaluating A Non-Invasive Tissue Perfusion Monitor

NCT04630704 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-11-16

No results posted yet for this study

Summary

The Pedra perfusion system will be used to assess changes in perfusion in response to physiological stimuli. It will be compared to other standard diagnostics.

Conditions

  • Circulatory; Change

Interventions

DEVICE

Pedra

Diffuse speckle contrast analysis perfusion system

Sponsors & Collaborators

  • Serena Group

    collaborator OTHER
  • Pedra Technology, PTE LTD

    lead INDUSTRY

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-07
Primary Completion
2021-04-01
Completion
2021-07-01
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04630704 on ClinicalTrials.gov